A Dual Topoisomerase Inhibitor, TAS-103, Induces Apoptosis in Human Cancer Cells
Authors:
- 1 June 1999
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 90 (6) , 691-698
Abstract
TAS‐103 (6‐[[2‐(dimethylamino)ethyl]amino]‐3‐hydroxy‐7H‐indeno[2,1‐c]quinolin‐7‐one dihydrochloride), a dual topoisomerase (topo) inhibitor, was developed as an anticancer agent by targeting topo I and topo II and has previously been shown to be effective against lung tumors. In this study, we investigated the cytotoxic activity of TAS‐103 in various human cancer cell lines (including gastric, colon, squamous, lung, and breast cancer cells) and the induction of apoptosis by TAS‐103. We next established stable transfectants of Bcl‐2 in the gastric cancer cell line AZ521 and found that Bcl‐2 blocked TAS‐103‐induced apoptosis. In addition, we demonstrated that the activities of ICE‐like and CPP32‐like proteases are involved in the signal transduction pathway of TAS‐103‐induced apoptosis. In summary, TAS‐103 is a novel type of anticancer agent with a unique mechanism and could be useful as a lead compound for development of new drugs.Keywords
This publication has 39 references indexed in Scilit:
- Proteases to die forGenes & Development, 1998
- Programmed Cell Death in Animal DevelopmentCell, 1997
- Target Cell Lysis by CTL Granule Exocytosis Is Independent of ICE/Ced-3 Family ProteasesImmunity, 1997
- Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32.Journal of Clinical Investigation, 1996
- ICE/CED-3 proteasesin apoptosisTrends in Cell Biology, 1996
- CPT-11 (Irinotecan) in the treatment of colorectal cancerEuropean Journal of Cancer, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Bcl-2 and the regulation of programmed cell deathJournal of Cell Biology, 1994
- Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3Cell, 1993
- Etoposide (VP-16–213)New England Journal of Medicine, 1985